Oscar Health Hits 7-Month High as Profits More-Than-Double

Oscar Health Inc. (NYSE:OSCR) is one of the 10 Stocks With Stunning Gains.

Oscar Health extended its winning streak to a 5th straight session on Tuesday to hit a seven-month high, as investors resumed buying positions following a stellar first-quarter performance, having more than doubled its net income during the period.

At intra-day trading, the stock climbed to as much as $23.76, or just 4-cents shy of its 52-week high of $23.80 in October 2025. It trimmed a few cents toward the end to be just up by 7.86 percent at $23.73 apiece.

Photo by Gustavo Fring on Pexels

The rally was primarily driven by continued optimism following news that its net income soared by 147 percent to $679 million from $275 million in the same period last year.

Revenues increased by 52 percent to $4.6 billion from $3.05 billion in the same period last year, thanks to higher rates and membership.

Following the results, Oscar Health Inc. (NYSE:OSCR) reaffirmed its outlook of $18.7 billion to $19 billion in revenues for full-year 2026, or an implied growth of 60 percent to 62 percent from the $11.7 billion posted in 2025.

It also expects to incur operating income of $250 million to $450 million, or a reversal of $396 million operating loss year-on-year.

While we acknowledge the risk and potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than OSCR and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.